Your browser doesn't support javascript.
Should we screen Eastern Mediterranean COVID-19 patients for inherited thrombophilia?
El Hasbani, Georges; Taher, Ali T.
  • El Hasbani G; Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
  • Taher AT; Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon. Electronic address: ataher@aub.edu.lb.
Med Hypotheses ; 152: 110621, 2021 Jul.
Article in English | MEDLINE | ID: covidwho-1253390
ABSTRACT
The inflammatory component of Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) creates a pro-thrombotic state that necessitates a thrombophylactic strategy for hospitalized patients. Such strategies are difficult to be standardized because certain individuals can have pro-thrombotic conditions, such as inherited thrombophilia, which pre-dispose them to an additional coagulative risk. Whether outside the hospital or when admitted, patients with inherited thrombophilia need special anticoagulant and antiplatelet attention. Identifying such patients, especially in susceptible populations like the eastern Mediterranean (EM) region, will aid primary providers in risk stratification for choosing the optimal anticoagulation or antiplatelet plan.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombosis / Thrombophilia / COVID-19 Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Med Hypotheses Year: 2021 Document Type: Article Affiliation country: J.mehy.2021.110621

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombosis / Thrombophilia / COVID-19 Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Med Hypotheses Year: 2021 Document Type: Article Affiliation country: J.mehy.2021.110621